Market closed
Kezar Life Sciences/$KZR
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Kezar Life Sciences
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.
Ticker
$KZR
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
58
Website
KZR Metrics
BasicAdvanced
$54M
Market cap
-
P/E ratio
-$13.55
EPS
0.21
Beta
-
Dividend rate
Price and volume
Market cap
$54M
Beta
0.21
52-week high
$7.35
52-week low
$6.85
Financial strength
Current ratio
9.581
Quick ratio
9.481
Long term debt to equity
7.792
Total debt to equity
11.687
Interest coverage (TTM)
-62.37%
Management effectiveness
Return on assets (TTM)
-28.07%
Return on equity (TTM)
-51.48%
Valuation
Price to revenue (TTM)
7.703
Price to book
0.36
Price to tangible book (TTM)
0.36
Price to free cash flow (TTM)
-0.681
Growth
Earnings per share change (TTM)
18.71%
3-year earnings per share growth (CAGR)
12.61%
KZR News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Kezar Life Sciences stock?
Kezar Life Sciences (KZR) has a market cap of $54M as of November 08, 2024.
What is the P/E ratio for Kezar Life Sciences stock?
The price to earnings (P/E) ratio for Kezar Life Sciences (KZR) stock is 0 as of November 08, 2024.
Does Kezar Life Sciences stock pay dividends?
No, Kezar Life Sciences (KZR) stock does not pay dividends to its shareholders as of November 08, 2024.
When is the next Kezar Life Sciences dividend payment date?
Kezar Life Sciences (KZR) stock does not pay dividends to its shareholders.
What is the beta indicator for Kezar Life Sciences?
Kezar Life Sciences (KZR) has a beta rating of 0.21. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.